Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2014 2
2018 1
2019 2
2020 1
2021 1
2022 5
2023 1
2024 3
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

17 results

Results by year

Filters applied: . Clear all
Page 1
The Non-Coding RNA Journal Club: Highlights on Recent Papers-10.
Pinzon Cortes JA, El-Osta A, Fontemaggi G, Delihas N, Miyazaki K, Goel A, Brazane M, Carré C, Dama P, Bayraktar S, Castellano L, Enguita FJ, Mitic T, Caporali A, Gerber AP, Amodio N. Pinzon Cortes JA, et al. Among authors: dama p. Noncoding RNA. 2022 Jan 10;8(1):3. doi: 10.3390/ncrna8010003. Noncoding RNA. 2022. PMID: 35076559 Free PMC article.
LncRNAs in breast cancer: a link to future approaches.
Sideris N, Dama P, Bayraktar S, Stiff T, Castellano L. Sideris N, et al. Among authors: dama p. Cancer Gene Ther. 2022 Dec;29(12):1866-1877. doi: 10.1038/s41417-022-00487-w. Epub 2022 Jul 4. Cancer Gene Ther. 2022. PMID: 35788171 Free PMC article. Review.
DLX6-AS1: a putative lncRNA candidate in multiple human cancers.
Sheykhhasan M, Ahmadyousefi Y, Seyedebrahimi R, Tanzadehpanah H, Manoochehri H, Dama P, Hosseini NF, Akbari M, Eslami Farsani M. Sheykhhasan M, et al. Among authors: dama p. Expert Rev Mol Med. 2021 Nov 26;23:e17. doi: 10.1017/erm.2021.17. Expert Rev Mol Med. 2021. PMID: 34823630 Review.
CAR T therapies in multiple myeloma: unleashing the future.
Sheykhhasan M, Ahmadieh-Yazdi A, Vicidomini R, Poondla N, Tanzadehpanah H, Dirbaziyan A, Mahaki H, Manoochehri H, Kalhor N, Dama P. Sheykhhasan M, et al. Among authors: dama p. Cancer Gene Ther. 2024 May;31(5):667-686. doi: 10.1038/s41417-024-00750-2. Epub 2024 Mar 4. Cancer Gene Ther. 2024. PMID: 38438559 Free PMC article. Review.
FOXR2 in cancer development: emerging player and therapeutic opportunities.
Yang P, Sheykhhasan M, Heidari R, Chamanara M, Dama P, Ahmadieh-Yazdi A, Manoochehri H, Tanzadehpanah H, Mahaki H, Kalhor N, Dirbaziyan A, Al-Musawi S. Yang P, et al. Among authors: dama p. Oncol Res. 2025 Jan 16;33(2):283-300. doi: 10.32604/or.2024.052939. eCollection 2025. Oncol Res. 2025. PMID: 39866234 Free PMC article. Review.
The functional role of LncRNA HOXA-AS2 in multiple human cancers.
Khoshandam M, Sideris N, Ahmadieh-Yazdi A, Sheykhhasan M, Manoochehri H, Tanzadehpanah H, Mahaki H, Ghadam M, Lak S, Kalhor N, Rabiei M, Al-Musawi S, Dama P. Khoshandam M, et al. Among authors: dama p. Pathol Res Pract. 2025 Feb;266:155795. doi: 10.1016/j.prp.2024.155795. Epub 2024 Dec 24. Pathol Res Pract. 2025. PMID: 39756105 Review.
17 results